APA

Santini D., Graziano F., Catalano V., Di Seri M., Testa E., Baldelli A. M., Giordani P., La Cesa A., Spalletta B., Vincenzi B., Russo A., Caraglia M., Virzi V., Cascinu S. & Tonini G. (20070924). Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial. : BMC cancer.

Chicago

Santini D, Graziano F, Catalano V, Di Seri M, Testa E, Baldelli A M, Giordani P, La Cesa A, Spalletta B, Vincenzi B, Russo A, Caraglia M, Virzi V, Cascinu S and Tonini G. 20070924. Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial. : BMC cancer.

Harvard

Santini D., Graziano F., Catalano V., Di Seri M., Testa E., Baldelli A. M., Giordani P., La Cesa A., Spalletta B., Vincenzi B., Russo A., Caraglia M., Virzi V., Cascinu S. and Tonini G. (20070924). Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial. : BMC cancer.

MLA

Santini D, Graziano F, Catalano V, Di Seri M, Testa E, Baldelli A M, Giordani P, La Cesa A, Spalletta B, Vincenzi B, Russo A, Caraglia M, Virzi V, Cascinu S and Tonini G. Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial. : BMC cancer. 20070924.